Switching to once-weekly insulin icodec versus once-daily insulin degludec in individuals with basal insulin-treated type 2 diabetes (ONWARDS 2): a phase 3a, randomised, open label, multicentre, treat-to-target trial

Authors :: Athena Philis-Tsimikas
Marisse Asong
Edward Franek
Ting Jia
Julio Rosenstock
Karolina Stachlewska
Hirotaka Watada
Monika Kellerer
Source :: The Lancet Diabetes & Endocrinology. 11:414-425
Publication Year :: 2023
Publisher :: Elsevier BV, 2023.

Subjects :: Endocrinology
Endocrinology, Diabetes and Metabolism
Internal Medicine

Tools